The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review

PLoS ONE - Tập 12 Số 2 - Trang e0171704
Cyprian Olchowy1, Kamil Cebulski2, Mateusz Łasecki1, Radosław Chaber3, Anna Olchowy2, Krzysztof Kałwak4, Urszula Zaleska–Dorobisz1
1Department of General and Pediatric Radiology, Wroclaw Medical University, Wrocław, Poland
2Radiology Students’ Scientific Club, Wrocław Medical University, Wroclaw, Poland Department of General and Pediatric Radiology, Wroclaw Medical University, Wroclaw, Poland
3Division of Hematology, Cancer Prevention and Propaedeutics of Rare Diseases, Faculty of Medicine, University of Rzeszow, Rzeszów, Poland
4Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wrocław, Poland

Tóm tắt

Từ khóa


Tài liệu tham khảo

P Caravan, 1999, Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications, Chem Rev, 99, 2293, 10.1021/cr980440x

T Kanda, 2014, High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material, Radiology, 270, 834, 10.1148/radiol.13131669

M Rogosnitzky, 2016, Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms, Biometals, 29, 365, 10.1007/s10534-016-9931-7

D Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097

L Roccatagliata, 2009, Multiple sclerosis: hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with the secondary progressive subtype, Radiology, 251, 503, 10.1148/radiol.2511081269

S Kasahara, 2011, Hyperintense dentate nucleus on unenhanced T1-weighted MR images is associated with a history of brain irradiation, Radiology, 258, 222, 10.1148/radiol.10100508

PH Lai, 1999, Hyperintense basal ganglia on T1-weighted MR imaging, AJR Am J Roentgenol, 172, 1109, 10.2214/ajr.172.4.10587157

M Port, 2008, Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review, Biometals, 21, 469, 10.1007/s10534-008-9135-x

T Kanda, 2015, High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration, Radiology, 275, 803, 10.1148/radiol.14140364

Y Cao, 2016, Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol, AJR Am J Roentgenol, 206, 414, 10.2214/AJR.15.15327

LD Weberling, 2015, Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration, Invest Radiol, 50, 743, 10.1097/RLI.0000000000000206

A Radbruch, 2015, High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol, Invest Radiol, 50, 805, 10.1097/RLI.0000000000000227

A Radbruch, 2015, Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent, Radiology, 275, 783, 10.1148/radiol.2015150337

CC Quattrocchi, 2015, Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy, Invest Radiol, 50, 470, 10.1097/RLI.0000000000000154

E Tedeschi, 2016, In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents, Eur Radiol

S Laurent, 2006, Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents, Contrast Media Mol Imaging, 1, 128, 10.1002/cmmi.100

J Ramalho, 2015, High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents, Radiology, 276, 836, 10.1148/radiol.2015150872

ML Kromrey, 2016, Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years, Eur Radiol

HH Hu, 2016, Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams, Pediatr Radiol, 10.1007/s00247-016-3646-3

RJ McDonald, 2015, Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging, Radiology, 275, 772, 10.1148/radiol.15150025

J Ramalho, 2016, Signal intensity change on unenhanced T1-weighted images in dentate nucleus following gadobenate dimeglumine in patients with and without previous multiple administrations of gadodiamide, Eur Radiol

M Birka, 2015, Diagnosis of nephrogenic systemic fibrosis by means of elemental bioimaging and speciation analysis, Anal Chem, 87, 3321, 10.1021/ac504488k

A Radbruch, 2016, Intraindividual Analysis of Signal Intensity Changes in the Dentate Nucleus After Consecutive Serial Applications of Linear and Macrocyclic Gadolinium-Based Contrast Agents, Invest Radiol, 51, 683, 10.1097/RLI.0000000000000308

DR Roberts, 2016, Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast, Brain Dev, 38, 331, 10.1016/j.braindev.2015.08.009

TF Flood, 2016, Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging, Radiology

S Sanyal, 2011, Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis—an autopsy-based review, Nephrol Dial Transplant, 26, 3616, 10.1093/ndt/gfr085

T Kanda, 2016, Brain gadolinium deposition after administration of gadolinium-based contrast agents, Jpn J Radiol, 34, 3, 10.1007/s11604-015-0503-5

N Murata, 2016, Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function, Invest Radiol, 51, 447, 10.1097/RLI.0000000000000252

EC Klawiter, 2013, Current and new directions in MRI in multiple sclerosis, Continuum (Minneap Minn), 19, 1058

Y Errante, 2014, Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation, Invest Radiol, 49, 685, 10.1097/RLI.0000000000000072

DA Stojanov, 2016, Increasing signal intensity within the dentate nucleus and globus pallidus on unenhanced T1W magnetic resonance images in patients with relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol, Eur Radiol, 26, 807, 10.1007/s00330-015-3879-9

J Agris, 2016, What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?, Eur Radiol, 26, 816, 10.1007/s00330-015-4019-2

T Grobner, 2006, Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?, Nephrol Dial Transplant, 21, 1104, 10.1093/ndt/gfk062

RC Cabot, 2010, Case records of the Massachusetts General Hospital: Case 38–2010: a 13-year-old girl with an enlarging neck mass, N Engl J Med, 363, 2445, 10.1056/NEJMcpc1004361

M Edward, 2008, Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis, J Pathol, 214, 584, 10.1002/path.2311

P Joffe, 1998, Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis, Acad Radiol, 5, 491, 10.1016/S1076-6332(98)80191-8

Y Cao, 2016, Effect of Renal Function on Gadolinium-Related Signal Increases on Unenhanced T1-Weighted Brain Magnetic Resonance Imaging, Invest Radiol

S Barbieri, 2016, High signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification, Contrast Media Mol Imaging, 11, 245, 10.1002/cmmi.1683

2016, Contrast Media Guidelines—version 8.1, ESUR Contrast Media Safety Committee, 05, 15

S Suzuki, 2000, Radiation-induced brain calcification: paradoxical high signal intensity in T1-weighted MR images, Acta Neurochir (Wien), 142, 801, 10.1007/s007010070095

S Khadilkar, 2016, A practical approach to diseases affecting dentate nuclei, Clin Radiol, 71, 107, 10.1016/j.crad.2015.09.010

ME Adin, 2015, Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium Administration, AJNR Am J Neuroradiol, 36, 1859, 10.3174/ajnr.A4378

LM Burke, 2016, Self-reported gadolinium toxicity: A survey of patients with chronic symptoms, Magn Reson Imaging, 34, 1078, 10.1016/j.mri.2016.05.005

J Ramalho, 2016, T1 Signal-Intensity Increase in the Dentate Nucleus after Multiple Exposures to Gadodiamide: Intraindividual Comparison between 2 Commonly Used Sequences, AJNR Am J Neuroradiol

M Tanaka, 2016, Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast, Eur Neurol, 75, 195, 10.1159/000445431

JH Miller, 2015, MRI Brain Signal Intensity Changes of a Child During the Course of 35 Gadolinium Contrast Examinations, Pediatrics, 136, e1637, 10.1542/peds.2015-2222